Doses of radioprotective agents used in trials of radioprotection: apropos of imidazole and naphazoline
Caravel, J.P.; Luu Duc, C.
Il Farmaco; Edizione Pratica 36(2): 49-57
1981
ISSN/ISBN: 0430-0912 PMID: 7215519 Document Number: 174416
Document emailed within 1 workday
Related Documents
Caravel, J.P.; Luu Duc, C. 1981: Doses of radioprotective agents used in trials of radioprotection: apropos of imidazole and naphazoline Il Farmaco; Edizione Pratica 36(2): 49-57Capizzi, R.L.; Oster, W. 2000: Chemoprotective and radioprotective effects of amifostine: an update of clinical trials International Journal of Hematology 72(4): 425-435
Vladimirov, V.G.; Dzharak'ian, T.K. 1974: Search for radioprotective agents in the USA Voenno-Meditsinskii Zhurnal 6: 86-88
Filip, J.; Sikulová, J.; Novák, L.; Hosek, B. 1971: Radioprotective effect of different doses of sodium fluoroacetate on mice irradiated in a gas mixture with a high oxygen concentration Physiologia Bohemoslovaca 20(3): 269-275
Fernandez, J.P.; Robbe, Y.; Chapat, J.P.; Cassanas, G.; Fatome, M.; Sentenac-Roumanou, H. 1986: Radioprotective agents derived from benzonitrile Il Farmaco; Edizione Scientifica 41(1): 41-48
Eidus, L.K.; Korystov, Y.N.; Kublik, L.N.; Vexler, A.M. 1982: Dependence of radioprotective effect of chemical modifying agents on their intracellular concentrations International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine 41(6): 625-632
Souto, E.B.; Müller, R.H. 2006: The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents Die Pharmazie 61(5): 431-437
Lushnikova, G.A. 1977: Toxicity and side effects of antibiotics in radiation sickness and during the use of aminothiol group radioprotective agents Antibiotiki 22(9): 825-829
Bergmann, J.F.; Lagier, G.; Calvo, F.; Chazelle, F.; Caulin, C. 1988: Independent controls of quality in therapeutic trials. Apropos of an experience of 11 external audits of clinical investigators performed in 2 European multicenter trials Therapie 43(5): 379-384
Wahhab, A.; Smith, J.R.; Ganter, R.C.; Moore, D.M.; Hondrelis, J.; Matsoukas, J.; Moore, G.J. 1993: Imidazole based non-peptide angiotensin II receptor antagonists. Investigation of the effect of the orientation of the imidazole ring on biological activity Arzneimittel-Forschung 43(11): 1157-1168
Dancey, J.E.; Schoenfeldt, M. 2003: Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor Oncology 17(6): 819; 826
Parquet, P.J. 1973: Clinical trials of Fenpentadiol in high doses Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 18(7): 836-841
Izbicki, R.; al-Sarraf, M.; Reed, M.L.; Vaughn, C.B.; Vaitkevicius, V.K. 1972: Further clinical trials with porfiromycin (NSC-56410) (large intermittent doses) Cancer ChemoTherapy Reports 56(5): 615-624
Minette, A. 1972: Bronchodilatation: apropos of several therapeutic trials Bulletin de Physio-Pathologie Respiratoire 8(3): 711-721
Warembourg, H.; Jaillard, J. 1974: Clinical trials with Fonlipol. Apropos of 50 cases Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 19(4 Suppl 11: 528-531
Goisis, M.; Servida, E.; Goisis, F. 1976: Treatment with high doses of progestational agents in endometrial adenocarcinoma Minerva Ginecologica 28(1): 87-96
Raymond, E.G.; Taylor, D.; Cates, W.; Tolley, E.E.; Borasky, D.; Cancel, A.; Masse, B.; Bukusi, E.A.; Johnson, B.R. 2007: Pregnancy in effectiveness trials of HIV prevention agents Sexually Transmitted Diseases 34(12): 1035-1039
Elia, G.; Vimercati, L.; Ambrosi, L. 1997: Risk assessment for exposure to low doses of carcinogenic agents: elements for debate La Medicina del Lavoro 88(3): 250-253
Kobayashi, K.; Takemoto, T.; Hino, M.; Hayashihara, K.; Nakahiro, K.; Wasai, S.; Niitani, H. 1992: Estimating doses of anti-cancer agents in sensitivity tests in vitro Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(3): 399-403
Zhiliaev, E.G.; Legeza, V.I.; Abdul', I.A. 1993: The efficacy of agents for the pharmacological protection of the body against exposure to low doses of irradiation Voenno-Meditsinskii Zhurnal 11: 15-18